P75.F Perpetua Medical AB (publ)
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -52.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is P75.F undervalued?
Graham numberThe Graham number of Perpetua Medical AB (publ) cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Perpetua Medical AB (publ) fundamental analysis
No fundamental analysis for Perpetua Medical AB (publ) yet.
Perpetua Medical AB (publ) stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Perpetua Medical AB (publ)
Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. It provides DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of drug preparations. The company formerly known as Pharmacolog i Uppsala AB (publ) a…
Full company profilePerpetua Medical AB (publ) financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Perpetua Medical AB (publ) annual financial statements (SEK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 10.1M | 9.94M | 6.94M | 14.6M | 21.9M |
| Gross Profit | 6.65M | 5.85M | 3.14M | 7.60M | 10.3M |
| Operating Income | -19.1M | -18.5M | -2.46M | 2.04M | -11.9M |
| EBITDA | -18.6M | -18.0M | -1.80M | 4.40M | -6.59M |
| Net Income | -19.2M | -18.3M | -2.47M | 2.45M | -8.48M |
| EPS | -19 | -6.62 | -0.55 | 0.54 | -0.99 |
| Balance Sheet | |||||
| Total Assets | 18.8M | 12.3M | 18.7M | 43.5M | 58.1M |
| Total Liabilities | 4.82M | 4.24M | 7.88M | 12.8M | 32.7M |
| Shareholders' Equity | 14.0M | 8.07M | 7.85M | 19.8M | 16.1M |
| Cash & Short-term Investments | 10.7M | 5.53M | 9.40M | 4.33M | 16.8M |
| Cash Flow | |||||
| Operating Cash Flow | -19.2M | -16.4M | -7.03M | -5.46M | -7.80M |
| Capital Expenditure | 1.51M | 620K | 33.4K | 2.75M | 5.50M |
| Free Cash Flow | -20.7M | -17.0M | -7.06M | -8.21M | -13.3M |
| Ratios | |||||
| ROE | -136.6% | -226.5% | -31.5% | 12.4% | -52.8% |
| ROA | -101.7% | -148.5% | -13.2% | 5.6% | -14.6% |
| Net Profit Margin | -189.5% | -183.9% | -35.6% | 16.8% | -38.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Perpetua Medical AB (publ) dividends
Perpetua Medical AB (publ) has not paid dividends in the last 4 fiscal years.
Last stock split: 0.041667:1 on Sep 26, 2024.
Who owns Perpetua Medical AB (publ)
- Insiders 46.29%
- Institutions 29.25%
- Public & others 24.46%
- Free float 6.60M
Perpetua Medical AB (publ) company profile
- Company name
- Perpetua Medical AB (publ)
- Ticker
- P75.F
- ISIN
- SE0022726311
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 12
- Fiscal year end
- December
- Address
- Knivstagatan 8, Uppsala, Sweden, SE-753 23
- Phone
- 46 1 87 11 332
- Website
- perpetuamedical.se
About Perpetua Medical AB (publ)
Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. It provides DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of drug preparations. The company formerly known as Pharmacolog i Uppsala AB (publ) and changed its name to Perpetua Medical AB (publ) in April 2024. Perpetua Medical AB (publ) was incorporated in 2007 and is headquartered in Uppsala, Sweden. Perpetua Medical AB (publ) operates as a subsidiary of Nolsterby Invest AB.
Perpetua Medical AB (publ) management
3- Mr. Anders HedlundCo-Founder & CEO · born 1985
- Mr. Hans DahlinFounder & Advisor to CEO
- Ms. Camilla LonnChief Financial Officer · born 1972